Professor Abraham (Avi) Israeli has returned to his role as Head of the Health Policy, Health Care Management and Health Economics Department at the Hebrew University – Hadassah Faculty of Medicine. Prior to this he was the Director General of the Israel Ministry of Health (2003-2009) and the Director – General of Hadassah Medical Organization (1998 -2001).
A Dr. Julian Rozan Professor of Family Medicine and Health Promotion Chair at the Hebrew University-Hadassah Medical School, Jerusalem (since 1996) and teaches there regularly.
Professor Israeli chaired the national committee to update the Israeli national standard basket of health services.
Professor Israeli received his medical degree and his master in Public Health from the Hadassah – Hebrew University Medical School. He completed residencies in Internal Medicine and in Health-Care Management at Hadassah University Hospital. He received his Master's Degree from the Sloan School of Management at MIT, Boston.
His scientific activities are related to applied, methodological and theoretical research in the fields of health policy, health care management, and the epidemiological, economic, social and cultural basis for decision-making.
His publications deal with translation of academic knowledge and inputs from the field into policy setting and decision-making processes.
Dr. Shorr has great stature in the biotechnology and pharmaceutical space. His expertise ranges from technological innovation, to strategic planning and implementation of research and business development, to the founding, financing and guiding of full commercialization of biotechnology ventures. Currently, Dr. Shorr is President of Cornerstone Pharmaceuticals, a company engaged in clinical development of a novel drug delivery technology for cancer. Concurrently, as a member of the Department of Biomedical Engineering at SUNY Stony Brook, he acts as Director of Business Development for the university's Center for Advanced Technology. Since 1999 he has also served as a trustee of Tissue Engineering Charities, Imperial College, London. In addition, he has continued financial interests and investments as a Principal in Altira Capital and Consulting LLC. Dr. Shorr was also Founder, VP Technology and Chief Scientific Officer for AT Biochem (later sold to FMC) and Associate Director, Department of Molecular Pharmacology at SmithKline and French from 1982 to 1988. He has published over 100 scientific/technical articles and has more than 100 inventions, issued or patent-pending worldwide, many of them commercialized. He holds a B.Sc. in Biology from the State University of Buffalo, a D.I.C. and a Ph.D. from the University of London.
Dr. Arbel was one of the founders of BrainStorm and served as its president until November 2004. Prior to joining BrainStorm, Dr. Arbel was the President and CEO of Pluristem, Inc., a stem cell research company traded on the OTCBB. From 1998 through 2002, Dr. Arbel served as national sales manager for Merck & Co. in Israel. Dr. Arbel is a member of the Neurological Association and American Society of Hematology. She is a certified chemical engineer and holds an MSc and a DSc in Medical Sciences from the Technion – Israel Institute of Technology.
Member of the board. Since 1995, Mr. Taub has been the Managing Member of Malcom S. Taub LLP, a law firm which practices in the areas of commercial litigation, among other practice areas. Mr. Taub also works on art transactions, in the capacity as an attorney and a consultant. Mr. Taub has also served as a principal of a firm which provides consulting services to private companies going public in the United States. Mr. Taub has acted as a consultant to the New York Stock Exchange in its Market Surveillance Department. Mr. Taub acts as a Trustee of The Gateway Schools of New York and The Devereux Glenholme School in Washington, Connecticut. Mr. Taub has served as an adjunct professor at Long Island University, Manhattan Marymount College and New York University Real Estate Institute. Mr. Taub holds a B.A. degree from Brooklyn College and a J.D. degree from Brooklyn Law School. Mr. Taub served on the Board of Directors of Safer Shot, Inc. (formerly known as Monumental Marketing Inc.), a company which trades on the Pink Sheets.
Rami Efrati brings with him an extensive management experience as well as worldwide business development, marketing and sales capabilities.
Acted 7 years as a VP sales, business development and marketing at NICE SYSTEMS in charge of government projects. Mr. Efrati is one of the founders and CEO of TeleFlight Technologies a technological company specializes in research and development of micro electronics solutions oriented mainly for unmanned systems.
Rami is also a LION’S member and serves the community as President of Givatayim Lions Club. Prior to that he was in charge of the international relations and co operation of LIONS Israel.
Mission
.jpg)
.jpg)
.gif)
